Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)
China
· Delayed Price · Currency is CNY 16.97
+0.13 (0.77%)
Mar 10, 2026, 2:15 PM CST
Beijing Scitop Bio-tech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,437 | 3,789 | 5,085 | 4,605 | 4,931 | 4,998 | Upgrade
|
| Market Cap Growth | 20.72% | -25.49% | 10.44% | -6.62% | -1.34% | - | Upgrade
|
| Enterprise Value | 3,626 | 3,049 | 4,624 | 4,075 | 4,417 | 4,415 | Upgrade
|
| Last Close Price | 16.84 | 14.25 | 18.94 | 19.98 | 21.05 | 21.05 | Upgrade
|
| PE Ratio | 44.30 | 40.16 | 54.40 | 41.90 | 45.02 | 51.75 | Upgrade
|
| Forward PE | 26.73 | 26.15 | 40.21 | 30.09 | 35.32 | - | Upgrade
|
| PS Ratio | 12.62 | 12.51 | 16.99 | 12.47 | 13.52 | 14.74 | Upgrade
|
| PB Ratio | 2.43 | 2.12 | 2.93 | 2.71 | 5.10 | 5.36 | Upgrade
|
| P/TBV Ratio | 2.52 | 2.18 | 3.03 | 2.81 | 5.41 | 5.48 | Upgrade
|
| P/FCF Ratio | - | - | - | 71.64 | 115.50 | 110.11 | Upgrade
|
| P/OCF Ratio | 41.45 | 26.66 | 47.41 | 31.02 | 44.72 | 74.97 | Upgrade
|
| EV/Sales Ratio | 10.32 | 10.07 | 15.45 | 11.04 | 12.11 | 13.02 | Upgrade
|
| EV/EBITDA Ratio | 33.55 | 32.24 | 55.80 | 32.58 | 42.25 | 38.99 | Upgrade
|
| EV/EBIT Ratio | 46.67 | 43.54 | 71.81 | 37.58 | 49.28 | 42.70 | Upgrade
|
| EV/FCF Ratio | -18.06 | - | - | 63.40 | 103.46 | 97.26 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.04 | 0.14 | 0.06 | 0.08 | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.12 | 0.20 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.44 | -0.46 | -0.47 | -0.68 | -0.58 | -0.63 | Upgrade
|
| Net Debt / EBITDA Ratio | -7.60 | -8.74 | -9.84 | -9.18 | -5.40 | -5.23 | Upgrade
|
| Net Debt / FCF Ratio | 4.04 | 11.92 | 11.45 | -17.87 | -13.23 | -13.04 | Upgrade
|
| Asset Turnover | 0.19 | 0.16 | 0.17 | 0.26 | 0.36 | 0.46 | Upgrade
|
| Inventory Turnover | 3.76 | 2.95 | 3.02 | 3.42 | 3.71 | 4.68 | Upgrade
|
| Quick Ratio | 10.46 | 9.23 | 15.26 | 14.83 | 11.09 | 11.12 | Upgrade
|
| Current Ratio | 11.58 | 9.93 | 16.30 | 15.56 | 12.05 | 11.91 | Upgrade
|
| Return on Equity (ROE) | 5.54% | 5.36% | 5.45% | 8.25% | 11.53% | 14.50% | Upgrade
|
| Return on Assets (ROA) | 2.56% | 2.35% | 2.23% | 4.79% | 5.49% | 8.82% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.79% | 6.46% | 8.05% | 19.96% | 21.04% | 27.56% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.20% | 3.80% | 3.70% | 6.40% | 9.20% | 11.10% | Upgrade
|
| Earnings Yield | 2.24% | 2.49% | 1.84% | 2.39% | 2.22% | 1.93% | Upgrade
|
| FCF Yield | -4.52% | -1.83% | -1.40% | 1.40% | 0.87% | 0.91% | Upgrade
|
| Dividend Yield | 0.90% | 1.05% | 0.79% | 1.00% | 1.58% | 1.76% | Upgrade
|
| Payout Ratio | 39.79% | 41.89% | 56.38% | 67.76% | 75.33% | - | Upgrade
|
| Buyback Yield / Dilution | 1.25% | 1.87% | -19.09% | -1.00% | -16.50% | -14.28% | Upgrade
|
| Total Shareholder Return | 2.15% | 2.92% | -18.30% | 0.00% | -14.92% | -12.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.